The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Lymphoma, T-Cell, Peripheral

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lymphoma, T-Cell, Peripheral


High impact information on Lymphoma, T-Cell, Peripheral


Chemical compound and disease context of Lymphoma, T-Cell, Peripheral


Biological context of Lymphoma, T-Cell, Peripheral


Anatomical context of Lymphoma, T-Cell, Peripheral


Gene context of Lymphoma, T-Cell, Peripheral


Analytical, diagnostic and therapeutic context of Lymphoma, T-Cell, Peripheral


  1. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Harabuchi, Y., Yamanaka, N., Kataura, A., Imai, S., Kinoshita, T., Mizuno, F., Osato, T. Lancet (1990) [Pubmed]
  2. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Bladergroen, B.A., Meijer, C.J., ten Berge, R.L., Hack, C.E., Muris, J.J., Dukers, D.F., Chott, A., Kazama, Y., Oudejans, J.J., van Berkum, O., Kummer, J.A. Blood (2002) [Pubmed]
  3. Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients. Zinzani, P.L., Baliva, G., Magagnoli, M., Bendandi, M., Modugno, G., Gherlinzoni, F., Orcioni, G.F., Ascani, S., Simoni, R., Pileri, S.A., Tura, S. J. Clin. Oncol. (2000) [Pubmed]
  4. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. Foss, H.D., Araujo, I., Demel, G., Klotzbach, H., Hummel, M., Stein, H. J. Pathol. (1997) [Pubmed]
  5. Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications. Pescarmona, E., Pignoloni, P., Santangelo, C., Naso, G., Realacci, M., Cela, O., Lavinia, A.M., Martelli, M., Russo, M.A., Baroni, C.D. J. Pathol. (1999) [Pubmed]
  6. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Fang, N.Y., Greiner, T.C., Weisenburger, D.D., Chan, W.C., Vose, J.M., Smith, L.M., Armitage, J.O., Mayer, R.A., Pike, B.L., Collins, F.S., Hacia, J.G. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  7. Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation. Chen, J., Williams, I.R., Lee, B.H., Duclos, N., Huntly, B.J., Donoghue, D.J., Gilliland, D.G. Blood (2005) [Pubmed]
  8. Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML. Maeda, T., Yagasaki, F., Ishikawa, M., Takahashi, N., Bessho, M. Blood (2005) [Pubmed]
  9. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Mathas, S., Jöhrens, K., Joos, S., Lietz, A., Hummel, F., Janz, M., Jundt, F., Anagnostopoulos, I., Bommert, K., Lichter, P., Stein, H., Scheidereit, C., Dörken, B. Blood (2005) [Pubmed]
  10. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients. Bekkenk, M.W., Vermeer, M.H., Jansen, P.M., van Marion, A.M., Canninga-van Dijk, M.R., Kluin, P.M., Geerts, M.L., Meijer, C.J., Willemze, R. Blood (2003) [Pubmed]
  11. The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma. Jones, D., Fletcher, C.D., Pulford, K., Shahsafaei, A., Dorfman, D.M. Blood (1999) [Pubmed]
  12. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. Ansell, S.M., Habermann, T.M., Kurtin, P.J., Witzig, T.E., Chen, M.G., Li, C.Y., Inwards, D.J., Colgan, J.P. J. Clin. Oncol. (1997) [Pubmed]
  13. Pentostatin (Nipent) in T-cell lymphomas. Kurzrock, R. Semin. Oncol. (2000) [Pubmed]
  14. Role of single-agent purine analogues in therapy of peripheral T-cell lymphomas. Dearden, C.E. Semin. Hematol. (2006) [Pubmed]
  15. Peripheral T-cell lymphomas: an evaluation of reproducibility of the updated Kiel classification. Hastrup, N., Hamilton-Dutoit, S., Ralfkiaer, E., Pallesen, G. Histopathology (1991) [Pubmed]
  16. CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature. Mohrmann, R.L., Arber, D.A. Mod. Pathol. (2000) [Pubmed]
  17. Tumor necrosis factor-beta gene expression and its relationship to the clinical features and histopathogenesis of peripheral T-cell lymphomas. Kato, H., Nagasaka, T., Ichikawa, A., Kinoshita, T., Murate, T., Tsushita, K., Hotta, T., Saito, H. Leuk. Lymphoma (1994) [Pubmed]
  18. Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype. Su, I.J., Lin, K.H., Chen, C.J., Tien, H.F., Hsieh, H.C., Lin, D.T., Chen, J.Y. Cancer (1990) [Pubmed]
  19. A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Brugnoni, D., Airó, P., Rossi, G., Bettinardi, A., Simon, H.U., Garza, L., Tosoni, C., Cattaneo, R., Blaser, K., Tucci, A. Blood (1996) [Pubmed]
  20. Leu-22 (L60). A more sensitive marker than UCHL1 for peripheral T-cell lymphomas, particularly large-cell types. Macon, W.R., Casey, T.T., Kinney, M.C., Collins, R.D., Cousar, J.B. Am. J. Clin. Pathol. (1991) [Pubmed]
  21. S-100 protein-positive sinusoidal large cell lymphoma. Chan, J.K., Ng, C.S., Chu, Y.C., Wong, K.F. Hum. Pathol. (1987) [Pubmed]
  22. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Jaffe, E.S., Chan, J.K., Su, I.J., Frizzera, G., Mori, S., Feller, A.C., Ho, F.C. Am. J. Surg. Pathol. (1996) [Pubmed]
  23. CD30 positive (non-anaplastic) peripheral T-cell lymphoma of the thyroid gland. Forconi, F., Bocchia, M., Marconcini, S., Bigazzi, C., Milani, M., Fraternali-Orcioni, G., Lauria, F. Haematologica (1999) [Pubmed]
  24. Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas. Dorfman, D.M., Greisman, H.A., Shahsafaei, A. Am. J. Pathol. (2003) [Pubmed]
  25. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified. Ishida, T., Inagaki, H., Utsunomiya, A., Takatsuka, Y., Komatsu, H., Iida, S., Takeuchi, G., Eimoto, T., Nakamura, S., Ueda, R. Clin. Cancer Res. (2004) [Pubmed]
  26. CD69 expression correlates with expression of other markers of Th1 T cell differentiation in peripheral T cell lymphomas. Dorfman, D.M., Shahsafaei, A. Hum. Pathol. (2002) [Pubmed]
  27. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease. Marafioti, T., Jabri, L., Pulford, K., Brousset, P., Mason, D.Y., Delsol, G. Br. J. Haematol. (2003) [Pubmed]
  28. Peripheral T-cell lymphomas. Immunoregulatory cytokine (interleukin-2, interleukin-4, and interferon-gamma) abnormalities and autologous mixed lymphocyte reaction. Raziuddin, S., Abu-Eshy, S., Sheikha, A. Cancer (1994) [Pubmed]
  29. Stem cell transplantation for peripheral T-cell lymphomas. Jantunen, E., D'Amore, F. Leuk. Lymphoma (2004) [Pubmed]
  30. Molecular evaluation of bone marrow involvement in peripheral T-cell lymphoma with a PCR-mediated RNase protection assay. Hanamura, A., Kinoshita, T., Kurokawa, T., Nagai, H., Murate, T., Nagasaka, T., Mori, H., Saito, H. Int. J. Hematol. (1999) [Pubmed]
WikiGenes - Universities